Purpose: To describe characteristics of choroidal osteomas (CO), using ocular ultrasound, fluorescein angiography, ultra-widefield retinal imaging, ultra-widefield autofluorescence, optical coherence tomography, enhanced-depth-imaging OCT, and OCT angiography (OCT-A).

Methods: Retrospective, observational case series study. Clinical records from patients with diagnosis of CO who underwent complete imaging evaluation were analyzed.

Results: Sixteen eyes from 11 patients were included. Mean patient age was 33.4 years (range 20-61), 72.7% were female, 100% were Hispanic, and 54.5% had unilateral CO. Median visual acuity was 20/150 (range 20/20-2000). CO was completely calcified in 25%, partially decalcified in 50%, and decalcified in 25%. Other features included choroidal neovascularization (18.75%), focal choroidal excavation (12.5%), choroidal depression associated to decalcification (18.75%), thinning of outer retina and photoreceptor layers over decalcified tumor (75%). Decreased fluorescence on FAF was observed in decalcified regions while relatively preserved fluorescence was observed in calcified regions.

Conclusions: Nowadays, diagnostic tests provide important information about each stage of choroidal osteoma. Progressive decalcification of the tumor might have a common pathogenic role for development of FCE or choroidal depression. OCT-A/FA proved to be valuable tools for detection of CNV in patients with CO.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092861PMC
http://dx.doi.org/10.1186/s40942-018-0132-0DOI Listing

Publication Analysis

Top Keywords

choroidal osteoma
8
choroidal depression
8
choroidal
7
multimodal imaging
4
imaging choroidal
4
osteoma purpose
4
purpose describe
4
describe characteristics
4
characteristics choroidal
4
choroidal osteomas
4

Similar Publications

Article Synopsis
  • The study examined 80 Indian patients with choroidal osteoma, focusing on demographic and clinical characteristics as well as treatment outcomes.
  • Most patients were female (61%), with the majority in their second decade of life; various associated complications like choroidal neovascularization (CNV) were noted in 40% of eyes.
  • Treatment methods included anti-VEGF therapy for CNV and other procedures, with mean best corrected visual acuity improving slightly over a follow-up period, indicating the need for ongoing monitoring despite the generally benign nature of the condition.
View Article and Find Full Text PDF

Choroidal osteoma is a rare, benign, osseous choristoma presenting as an orange-yellow, well-defined fundus mass. It presents unilaterally in most cases, has a predilection for the female sex, and favor a juxtapapillary location, becoming clinically manifest when it involves the macula. Almost 60% of eyes with osteoma may suffer significant visual loss.

View Article and Find Full Text PDF

Purpose: To describe the use of anti-osteoclastic medications (i.e., bisphosphonates and receptor activator of nuclear factor kappa beta (RANK) ligand inhibitors) in treating choroidal osteoma.

View Article and Find Full Text PDF

A choroidal osteoma (CO) is a relatively rare, benign tumor with ossification that develops in the choroid and undergoes enlargement and decalcification in its natural course. Photodynamic therapy (PDT) is used to induce decalcification, but there are few reports on individual cases treated with PDT. A 47-year-old Japanese man who had reduced decimal visual acuity (VA) of the right eye to 0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!